TME iLab and Spatial Omics: Astellas Pharma’s Vision for New Drug Discovery Opportunities

2024.12.20
Astellas Pharma is a global life science company dedicated to transforming scientific progress into “value” for patients. The company focuses its researc… 黒澤伸行

Innovation in Spatial Biology: Next-Generation Protein Imaging and Its Applications

2024.10.07
Spatial biology is a field of study that explores how cells, genes, and proteins are arranged and interact within and between tissues. By using advanced tec… 黒澤伸行

Introducing RareCyte, Inc.

2024.07.19
RareCyte is an innovative, microenvironment-focused company that has developed technologies and end-to-end integrated platforms to accelerate research in oncology, immuno-oncology, maternal-fetal healt… 黒澤伸行

Issue No. 7: Baseline Research and Biomarker Exploration

2024.07.18
It is believed that it will take at least 10 years for the drugs currently under development to begin practical use. By then, the overall healthcare system surrounding drugs is expected to differ significantl… 黒澤伸行

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

2024.07.05
This series is based on the recognition that “drug development is entering a major t… 黒澤伸行

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

2024.07.03
This series is based on the recognition that “drug development is entering a major turning point,” with its main theme… 黒澤伸行

Issue No. 3: Can the ‘Pipeline’ of Drug Development Be Reconsidered?

2024.06.29
This series begins with the recognition that drug development is entering a significant turning point. The main theme is to anticipate the next era from th… 黒澤伸行

Issue No. 2: From Drug Discovery and Development to Precision Medicine

2024.06.21
Recently, three acquisition reports in the pharmaceutical industry have drawn significant attention: Takeda Pharmaceutical’s acqui… 黒澤伸行

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Biomarkers

TME iLab and Spatial Omics: Astellas Pharma’s Vision for New Drug Discovery Opportunities

Innovation in Spatial Biology: Next-Generation Protein Imaging and Its Applications

Introducing RareCyte, Inc.

Issue No. 7: Baseline Research and Biomarker Exploration

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

Issue No. 3: Can the ‘Pipeline’ of Drug Development Be Reconsidered?

Issue No. 2: From Drug Discovery and Development to Precision Medicine

Recent Posts

Event Schedule

calender

Popular Posts

Biomarkers

TME iLab and Spatial Omics: Astellas Pharma’s Vision for New Drug Discovery Opportunities

Innovation in Spatial Biology: Next-Generation Protein Imaging and Its Applications

Introducing RareCyte, Inc.

Issue No. 7: Baseline Research and Biomarker Exploration

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

Issue No. 3: Can the ‘Pipeline’ of Drug Development Be Reconsidered?

Issue No. 2: From Drug Discovery and Development to Precision Medicine

Recent Posts

Tag Cloud

Event Schedule

calender

Popular Posts